China Money Network
Login
Join

China’s Zixin Pharma To Invest $42M In US Genome Mapping Firm Nabsys 2.0

  • July 22, 2016 — 15:38 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese drug maker Jilin Zixin Pharmaceutical Industrial Co., Ltd. has agreed to invest US$42 million in Nabsys 2.0, a U.S. high definition genome mapping firm.... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: